(ARQL) Company News for January 18, 2012 – Corporate Summary

•    Bio technology company ArQule Inc.’s (NASDAQ:ARQL) share prices gained 11.91% to close at $6.67 after the company’s experimental treatment for liver cancer reported a positive outcome in its Phase II trial

•  ...